KaydedilenlerDerginizi ekleyin

Dergiler / Mucosa / 2023 / Cilt: 6 - Sayı: 1

Eksfolyatif keilit tedavisinde tildrakizumab

Tildrakizumab for the treatment of exfoliative cheilitis

Timothy COWAN, Nada ABU ALRUB, Anna WİLSON, Mani MAKHİJA, Dedee MURRELL

Dergi
Mucosa
Sayfa
19–21
DOI
—

Abstract

Exfoliative cheilitis is an inflammatory condition that can significantly impair quality of life. This is the first reported case of an interleukin-23 inhibitor, tildrakizumab, for the treatment of a chronic, refractory case of exfoliative cheilitis.

Anahtar kelimeler: biyolojik, keilit, tildrakizumab, interlökin-23, dermatoloji

Eksfolyatif keilit tedavisinde tildrakizumab — AJIndex